Investors Grab APLS Even Lower Than Its Secondary Stock Offering
December 06, 2021 at 13:21 PM EST
Looking back to 20 days ago, Apellis Pharmaceuticals Inc (APLS) priced a 8,750,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..